Skip to main content
. Author manuscript; available in PMC: 2023 Jul 7.
Published in final edited form as: Mol Cell. 2022 May 4;82(13):2370–2384.e10. doi: 10.1016/j.molcel.2022.04.010

Figure 5. METTL3 associates with chromatin of p53 target genes.

Figure 5.

(A) ChIP analysis of METTL3 binding to p53 sites in p53 target gene loci, relative to input, in dox-treated E1A;HRasG12V MEFs.

(B) ChIP analysis of METTL3 binding to p53 sites in p53 target gene loci, relative to input, in dox-treated E1A;HRasG12V wild-type and p53−/− MEFs. In (A) and (B), IgG serves as a negative control antibody, and representative analysis from two biological replicates is shown.